MAXIM PHARMACEUTICALS INC
- CIK: 0001013351
- EIN: 87-0279983
- Business address: 8899 UNIVERSITY CTR LANE, STE 400, SAN DIEGO, California, 92122
Information
Mailing address
8899 UNIVERSITY CENTER LANE, STE 400, SAN DIEGO, Delaware, 92122Phone
8584534040State location
CaliforniaState of incorporation
DelawareFiscal year end
September 30SIC
2833 - (CF Office: Office of Life Sciences) MEDICINAL CHEMICALS & BOTANICAL PRODUCTSFilings
N/A
About MAXIM PHARMACEUTICALS INC
MAXIM PHARMACEUTICALS INC (CIK: 0001013351) is an American company incorporated in the state of California. Head office is located at 8899 UNIVERSITY CTR LANE, STE 400, SAN DIEGO, California, 92122. Work in the industry 2833 - (CF Office: Office of Life Sciences) MEDICINAL CHEMICALS & BOTANICAL PRODUCTS. MAXIM PHARMACEUTICALS INC is a public company and trade via Over-The-Counter (OTC).Ownership
| Owner | Filings | Transaction Date | Type of Owner |
|---|---|---|---|
| YETTER WAYNE P | 0001215120 | Jan-04-2006 | director |
| TOWNSEN FULTON DUWAINE | 0001215911 | Jan-04-2006 | director |
| MARTENSSON PEROLAF | 0001215912 | Jan-04-2006 | director |
| ZERBE ROBERT L MD | 0001220363 | Jan-04-2006 | director |
| Bedard John F | 0001305387 | Jan-04-2006 | director |
| Prunty John D | 0001306376 | Jan-04-2006 | officer: Chief Financial Officer |
| STAMBAUGH LARRY G | 0001215909 | Aug-03-2005 | officer: Chairman,CEO and President |
| FRASHIER GARY E | 0001215914 | Feb-19-2004 | director |
| HEINRICHS THEODOR H | 0001215916 | Feb-19-2004 | director |
| TONETTA SHARON A | 0001271326 | Dec-01-2003 | officer: V.P.,Drug Development |
| GEHLSEN KURT R | 0001215906 | Nov-20-2003 | officer: Chief Scientific Officer |
| ALTIG ANTHONY E | 0001215907 | Nov-20-2003 | officer: Chief Financial Officer |
| GLEASON PAMELA GEE | 0001215908 | Nov-20-2003 | officer: Vice President, Human Resource |
Stock Chart
Coming soon!
Jobs
Coming soon!
Recent SEC Filings
Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by MAXIM PHARMACEUTICALS INC
| Filings | Format | Description | Filed/Effective | File/Film Number |
|---|---|---|---|---|
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001104659-06-001057 ( Act) Size: 15 KB |
Jan-06-2006 | |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001104659-06-001052 ( Act) Size: 12 KB |
Jan-06-2006 | |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001104659-06-001051 ( Act) Size: 10 KB |
Jan-06-2006 | |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001104659-06-001045 ( Act) Size: 37 KB |
Jan-06-2006 | |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001104659-06-001044 ( Act) Size: 19 KB |
Jan-06-2006 | |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001104659-06-001043 ( Act) Size: 34 KB |
Jan-06-2006 | |
| 4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001104659-06-001042 ( Act) Size: 6 KB |
Jan-06-2006 | |
| 15-12B | Document | Notice of termination of registration of a class of securities under Section 12(b) Acc-no: 0001104659-06-000409 (34 Act) Size: 23 KB |
Jan-05-2006 | 06509253 |
| 8-K | Document | Current report filing Acc-no: 0001104659-05-062019 (34 Act) Size: 45 KB |
Dec-21-2005 | 051278404 |
| 10-K | Document | Annual report pursuant to section 13 and 15(d) Acc-no: 0001104659-05-060826 (34 Act) Size: 2734 KB |
Dec-14-2005 | 051264541 |
| DEFA14A | Document | Additional definitive proxy solicitation materials Acc-no: 0000950123-05-014729 (34 Act) Size: 52 KB |
Dec-14-2005 | 051263199 |
| 8-K | Document | Current report filing Acc-no: 0001104659-05-060710 (34 Act) Size: 136 KB |
Dec-14-2005 | 051262995 |
| DEFA14A | Document | Additional definitive proxy solicitation materials Acc-no: 0000950123-05-014512 (34 Act) Size: 28 KB |
Dec-08-2005 | 051250793 |
| DEFA14A | Document | Additional definitive proxy solicitation materials Acc-no: 0000950123-05-014509 (34 Act) Size: 25 KB |
Dec-08-2005 | 051250777 |
| DEFA14A | Document | Additional definitive proxy solicitation materials Acc-no: 0000950123-05-014375 (34 Act) Size: 20 KB |
Dec-05-2005 | 051242242 |
| DEFA14A | Document | Additional definitive proxy solicitation materials Acc-no: 0000950123-05-014260 (34 Act) Size: 31 KB |
Dec-01-2005 | 051235702 |
| DEFA14A | Document | Additional definitive proxy solicitation materials Acc-no: 0000950123-05-014141 (34 Act) Size: 10 KB |
Nov-28-2005 | 051229166 |
| 425 | Document | Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions Acc-no: 0000950123-05-013643 (34 Act) Size: 32 KB |
Nov-14-2005 | 051202773 |
| 425 | Document | Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions Acc-no: 0000950123-05-013641 (34 Act) Size: 32 KB |
Nov-14-2005 | 051202737 |
| DEFM14A | Document | Definitive proxy statement relating to a merger,acquisition, or disposition Acc-no: 0000950123-05-013492 (34 Act) Size: 3432 KB |
Nov-10-2005 | 051195131 |
Recent 20 filings. View all MAXIM PHARMACEUTICALS INC filings
Reviews
Catherine
Thanks I look forward to using the product to improve my skin tone
Ryan Storey
Huge help thank you for your help .. y'all make it so much easier
Pelisari
young lad who new his job ansered questions and new what was best for me.
Frequently Asked Questions
Tags:
- MAXIM PHARMACEUTICALS INC overview
- MAXIM PHARMACEUTICALS INC job
- MAXIM PHARMACEUTICALS INC stock
- MAXIM PHARMACEUTICALS INC ownership
- MAXIM PHARMACEUTICALS INC CEO
- MAXIM PHARMACEUTICALS INC documents
Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.
Orther Companies
Cordyceps Sunshine Biotech Holdings Co., Ltd.
Update: Jan 21, 2023
PSLY.COM, Inc.
Update: Aug 29, 2022
Jushi Holdings Inc.
Update: Aug 29, 2022
ZACHARY VENTURES INC
Update: Aug 25, 2022
WEIKANG BIO-TECHNOLOGY GROUP CO., INC.
Update: Aug 25, 2022
VITAQUEST INTERNATIONAL INC
Update: Aug 24, 2022
Latest News
SEC Adopts Rules to Improve Clearing Agency Governance and Mitigate...
Charter Communications to Pay $25 Million Penalty for Unauthorized...
SEC Announces Enforcement Results for Fiscal Year 2023
SEC Charges Former Co-CEOs of Tech Start-Up Bitwise Industries...
SEC Charges Royal Bank of Canada with Internal Accounting Controls...
SEC Charges President/CCO of Prophecy Asset Management Advisory...
SEC Adopts Rules for the Registration and Regulation of Security-Based...
SEC Charges Crypto Company SafeMoon and its Executive Team for...
© 2022 